P702: Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres
ECCO '19 Copenhagen
2019
P703: The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study
ECCO '19 Copenhagen
2019
P704: Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease
ECCO '19 Copenhagen
2019
P705: Incidence and risk factors of micronutrient deficiency in the patients with inflammatory bowel disease in Korea: folate, vitamin B12, 25-OH-vitamin D, ferritin
ECCO '19 Copenhagen
2019
P706: Patient knowledge towards biological treatment in inflammatory bowel diseases: a cross-sectional survey
ECCO '19 Copenhagen
2019
P707: 38 Weeks treatment of UC patients with different daily doses of mesalazine
ECCO '19 Copenhagen
2019
P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool
ECCO '19 Copenhagen
2019
P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P710: The use of first-line biologics in patients with Crohn’s disease in Norway from 2011 to 2016
ECCO '19 Copenhagen
2019
P711: The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study
ECCO '19 Copenhagen
2019
P712: Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use
ECCO '19 Copenhagen
2019
P713: Long-term efficacy of endoscopic balloon dilatation using single-balloon enteroscopy in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study
ECCO '19 Copenhagen
2019
P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
ECCO '19 Copenhagen
2019
P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy
ECCO '19 Copenhagen
2019
P717: The use of combination biologic therapy in inflammatory bowel disease: A single tertiary-centre experience
ECCO '19 Copenhagen
2019
P718: Risk of tuberculosis in patients with inflammatory bowel disease receiving biologics using two interferon-γ release assays as monitoring
ECCO '19 Copenhagen
2019
P719: Update of a network meta-analysis of efficacy and safety of different intravenous iron compounds in patients with IBD and anaemia
ECCO '19 Copenhagen
2019